Hematology Disease Topics & Pathways:
Research, Fundamental Science, Clinical Practice (Health Services and Quality), Translational Research, Clinical Research, Diversity, Equity, and Inclusion (DEI)
“Race and Science: Bench to Bedside to the Community
Dr. Alisa Wolberg will discuss the role of the basic scientist and how the concepts of diversity, equity, and inclusion may be considered when designing investigations and experiments that will lead to data that is broadly generalizable and applicable.
Dr. Saad Usmani will address the next step, regarding moving basic science to the bedside and discussing strategies that assure clinical trials with novel therapies are inclusive and diverse.
Ms. Shonta Chambers will provide the patient perspective and will highlight how best to engage with community and national organizations to strengthen the relationship between patients and the health care team to achieve the goal of equitable access to care and innovation.
Dr. Nicole Gormley will present on the US Food and Drug Administration’s guidance on “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials.” She will highlight the potential impact that regulatory agencies may have on clinical trial development.